Stock data
Bone Biologics Corp (BBLG)
Bone Biologics Corp (BBLG) reported net income of -US$3.11M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$3.23M | -US$3.11M | — |
| 2024 | — | — | -US$4.22M | -US$4.11M | — |
| 2023 | — | — | -US$9.43M | -US$8.95M | — |
| 2022 | — | — | -US$3.67M | -US$1.48M | — |
| 2021 | — | — | -US$1.10M | -US$1.61M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$0.77M | — |
| 2026-03-31 | — | -US$0.77M | — |
| 2025-12-31 | — | -US$0.68M | — |
| 2025-09-30 | — | -US$0.67M | — |
| 2025-06-30 | — | -US$0.74M | — |
| 2025-03-31 | — | -US$1.02M | — |
| 2024-12-31 | — | -US$1.52M | — |
| 2024-09-30 | — | -US$0.94M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.